Dugel Pravin 4

What Happened
Pravin Dugel (Executive Chairman, President and CEO) reported transferring 50,092 shares of Ocular Therapeutix on June 16, 2026. The transaction is coded as a gift (G); the reported price per share is $0.00 and the total reported consideration is $0.

Key Details

• Transaction date: 2026-06-16; Form 4 filed: 2026-06-18 (filed two days after the transaction).
• Transaction type/code: Gift (G). Price per share reported: $0.00; total consideration: $0.
• Shares transferred: 50,092 shares to the reporting person’s spouse (footnote: “transferred to his spouse for no consideration”).
• Shares owned after the transaction: Not stated on the information provided in this summary (not reported in the supplied transaction details).
• No 10b5-1 plan, tax-withholding, or cashless exercise indicated.

Context
Gifts of shares are a non‑market transaction and do not necessarily signal the insider’s view of the company’s prospects. This transfer was to a spouse and involved no cash consideration. The filing appears to have been made within the normal Form 4 reporting window (two business days).